Theralink Technologies, Inc. OBMP OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score

29/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Theralink Technologies, Inc. (OBMP) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 27/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

29/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

25/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

→ Health

MOAT

50/100

→ Income

GROWTH

58/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — OBMP

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio16,567.52

EV/EBITDA0.0

Per Share Data

EPS (TTM)$0.00

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2012	$0.00	$781.05K	$-975.11K	-124.8%
2013	$0.00	$77.94K	$-361.77K	-464.2%
2014	$0.00	$24.00	$-597.64K	-2490158.3%
2015	$0.00	$74.00	$-573.55K	-775063.5%
2016	$-27.30	$0.00	$-2.12M	-
2017	$-93.12	$0.00	$-16M	-
2018	$0.01	$0.00	$4.34M	-
2019	$-0.02	$0.00	$-11.2M	-
2020	$-0.04	$181.23K	$-3.2M	-1766.5%
2021	$0.00	$505.6K	$-5.59M	-1106.2%